The estimated Net Worth of Jennifer Lynn Ziolkowski is at least $3.96 Milión dollars as of 27 January 2021. Ms. Ziolkowski owns over 11,500 units of Solid Biosciences Inc stock worth over $2,539,926 and over the last 7 years she sold SLDB stock worth over $0. In addition, she makes $1,420,180 as Chief Financial Officer a Treasurer at Solid Biosciences Inc.
Sign up
Ms. Ziolkowski SLDB stock SEC Form 4 insiders trading
Jennifer has made over 2 trades of the Solid Biosciences Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently she exercised 11,500 units of SLDB stock worth $86,135 on 27 January 2021.
The largest trade she's ever made was exercising 11,500 units of Solid Biosciences Inc stock on 27 January 2021 worth over $86,135. On average, Jennifer trades about 3,286 units every 26 days since 2018. As of 27 January 2021 she still owns at least 339,109 units of Solid Biosciences Inc stock.
You can see the complete history of Ms. Ziolkowski stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jennifer Ziolkowski biography
Jennifer Ziolkowski is no longer serves as Chief Financial Officer, Treasurer of the Company effective 1/29/2021. Prior to joining us, she served as the Head of Sales Operations, North America for Philips Healthcare, a healthcare company, from 2014 to 2017 and as its Senior Director of Finance, North America from 2012 to 2014. Ms. Ziolkowski served as Controller of Medical Consumables and Sensors from 2010 to 2012, Director of Finance of Imaging Systems from 2008 to 2010, Senior Director of Finance and Corporate Controller from 2007 to 2008 at TransMedics, Inc., a medical device company, and held various finance and corporate development leadership positions at Cytyc Corporation, a medical technology company, from 2001 to 2007. From 1996 to 2001, Ms. Ziolkowski gained significant experience at PricewaterhouseCoopers LLP where she served as a Senior Transaction Services Consultant and as Audit Senior and Staff in the Boston Technology Group. Ms. Ziolkowski holds a B.S. in Accounting from Boston College and is a Certified Public Accountant.
What is the salary of Jennifer Ziolkowski?
As the Chief Financial Officer a Treasurer of Solid Biosciences Inc, the total compensation of Jennifer Ziolkowski at Solid Biosciences Inc is $1,420,180. There are 2 executives at Solid Biosciences Inc getting paid more, with Carl Morris having the highest compensation of $4,052,210.
How old is Jennifer Ziolkowski?
Jennifer Ziolkowski is 46, she's been the Chief Financial Officer a Treasurer of Solid Biosciences Inc since 2019. There are 17 older and 4 younger executives at Solid Biosciences Inc. The oldest executive at Solid Biosciences Inc is Stephen J. DiPalma M.B.A., 62, who is the Treasurer & Principal Accounting Officer.
What's Jennifer Ziolkowski's mailing address?
Jennifer's mailing address filed with the SEC is C/O SOLID BIOSCIENCES INC., 141 PORTLAND STREET, FIFTH FLOOR, CAMBRIDGE, MA, 02139.
Insiders trading at Solid Biosciences Inc
Over the last 7 years, insiders at Solid Biosciences Inc have traded over $9,620,465 worth of Solid Biosciences Inc stock and bought 13,973,934 units worth $97,227,521 . The most active insiders traders include Advisors Llcperceptive Life..., Capital Management, L.P.Ra ... a Rajeev M. Shah. On average, Solid Biosciences Inc executives and independent directors trade stock every 38 days with the average trade being worth of $1,822,871. The most recent stock trade was executed by Ian F Smith on 3 July 2024, trading 3,255 units of SLDB stock currently worth $24,380.
What does Solid Biosciences Inc do?
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.
What does Solid Biosciences Inc's logo look like?
Complete history of Ms. Ziolkowski stock trades at Solid Biosciences Inc
Solid Biosciences Inc executives and stock owners
Solid Biosciences Inc executives and other stock owners filed with the SEC include:
-
Carl Morris,
Chief Scientific Officer -
Ilan Ganot,
President, Chief Executive Officer, Co-Founder, Director -
Jennifer Ziolkowski,
Chief Financial Officer, Treasurer -
Ilan Ganot,
Co-founder, Pres, CEO & Director -
Dr. Carl Ashley Morris,
Chief Scientific Officer -
Adam Koppel,
Independent Director -
Lynne Sullivan,
Independent Director -
Martin Freed,
Independent Director -
Dr. Andrey Juan Zarur Ph.D.,
Co-Founder -
Adam Stone,
Independent Director -
Sukumar Nagendran,
Independent Director -
Matthew Arnold,
Independent Director -
Rajeev Shah,
Independent Director -
Robert Huffines,
Independent Director -
Ian F. Smith A.C.A., ACA, C.P.A., CPA,
Exec. Chair -
Matthew Bennett Arnold,
Co-Founder & Board Member -
Carlo Tanzi,
IR Contact Officer -
Lynette Herscha,
Chief Legal Officer and Secretary -
Joel Schneider,
Chief Technology Officer and Head of Exploratory Research and Development -
Ian Smith,
Chairman of the Board -
Gilad David Hayeem,
Co-Founder -
Dr. Cathryn M. Clary M.B.A., M.D.,
Acting Chief Medical Officer -
Erin Powers Brennan,
Chief Legal Officer & Sec. -
Caitlin Lowie,
VP of Communications & IR -
Stephen J. DiPalma M.B.A.,
Treasurer & Principal Accounting Officer -
Dr. Joel Solomon Zev Schneider Ph.D.,
Chief Operating Officer -
Michael Inbar CPA, M.B.A.,
Sr. VP of Fin. -
Annie Ganot,
Co-Founder & Director of Patient Advocacy -
Pedro Alvaro Amorrortu,
Chief Operating Officer -
Jorge Armando Quiroz,
Chief Medical Officer -
Capital Management, L.P.Ra ...,
-
Advisors Llcperceptive Life...,
-
Chase & Cojpmc Strategic In...,
-
Advisors Llcedelman Joseph ...,
-
Gilad David Hayeem,
10% owner -
Juan Andrey Zarur,
Director -
Kevin Tan,
CFO & Treasurer -
Capital, Llc Boxer,
10% owner -
Capital Management, L.P.Ra ...,
-
Capital Life Sciences Inves...,
-
Advisors Llcperceptive Life...,
-
Capital Management, L.P.Ra ...,
-
Jessie Hanrahan,
Chief Regulatory Officer -
Erin Powers Brennan,
Chief Legal Officer, Secretary -
Clare Kahn,
-
Advisors Llcperceptive Life...,
-
David T Howton,
Chief Operating Officer -
Jennifer Marlowe,
CSO -
Alexander Cumbo,
President and CEO -
Paul Herzich,
Chief Technology Officer -
Gabriel Brooks,
Chief Medical Officer -
Georgia Keresty,